AU4075897A - A leptin binding protein and its use in methods for diagnosing and treating abnormalities of the endogenous leptin pathway - Google Patents
A leptin binding protein and its use in methods for diagnosing and treating abnormalities of the endogenous leptin pathwayInfo
- Publication number
- AU4075897A AU4075897A AU40758/97A AU4075897A AU4075897A AU 4075897 A AU4075897 A AU 4075897A AU 40758/97 A AU40758/97 A AU 40758/97A AU 4075897 A AU4075897 A AU 4075897A AU 4075897 A AU4075897 A AU 4075897A
- Authority
- AU
- Australia
- Prior art keywords
- leptin
- diagnosing
- methods
- binding protein
- pathway
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/02—Nutritional disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69902996A | 1996-08-16 | 1996-08-16 | |
US2368596P | 1996-08-16 | 1996-08-16 | |
US08699029 | 1996-08-16 | ||
US60023685 | 1996-08-16 | ||
PCT/US1997/014597 WO1998006752A1 (en) | 1996-08-16 | 1997-08-15 | A leptin binding protein and its use in methods for diagnosing and treating abnormalities of the endogenous leptin pathway |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4075897A true AU4075897A (en) | 1998-03-06 |
Family
ID=26697488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU40758/97A Abandoned AU4075897A (en) | 1996-08-16 | 1997-08-15 | A leptin binding protein and its use in methods for diagnosing and treating abnormalities of the endogenous leptin pathway |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4075897A (en) |
WO (1) | WO1998006752A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6777388B1 (en) | 1998-08-21 | 2004-08-17 | Clf Medical Technology Acceleration Program, Inc. | Leptin-related peptides |
EP1276771A4 (en) * | 2000-03-10 | 2003-06-04 | Thomas Jefferson Univarsity | Sensitive detection of wild-type and mutant egfr by specific elisa assays in any biological sample |
WO2002079415A2 (en) | 2001-03-30 | 2002-10-10 | Lexigen Pharmaceuticals Corp. | Reducing the immunogenicity of fusion proteins |
JP2010526132A (en) * | 2007-05-07 | 2010-07-29 | ユニヴァーシティー オブ ウルサン ファウンデイション フォー インダストリー コーオペレイション | Method for prevention or treatment of body weight disease using clusterin |
BR112019004715A2 (en) * | 2016-09-12 | 2019-07-16 | Aegerion Pharmaceuticals Inc | methods for detecting neutralizing anti-leptin antibodies |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3933850A1 (en) * | 1989-10-06 | 1991-04-18 | Schering Ag | CYTOLYSIS INHIBITOR (ZLI), A DNA SEQUENCE ENCODING THIS BLOOD PLASMA PROTEIN, AND A PLASMIDE, A HOST ORGANISM AND A METHOD FOR OBTAINING THIS PROTEIN |
US7063958B1 (en) * | 1996-01-16 | 2006-06-20 | The Rockefeller University | Nucleic acids db, the receptor for leptin |
-
1997
- 1997-08-15 WO PCT/US1997/014597 patent/WO1998006752A1/en active Application Filing
- 1997-08-15 AU AU40758/97A patent/AU4075897A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1998006752A1 (en) | 1998-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3373297A (en) | Electrochemical test device and related methods | |
AU4648697A (en) | Methods and devices for preparing protein concentrates | |
AU5721798A (en) | Human mage-like protein | |
AUPN766296A0 (en) | Trocar and introducing kit | |
AU6487098A (en) | Improved electrosurgical hemostatic method and device | |
AU4160096A (en) | Probe card assembly and kit, and methods of using same | |
AU4907897A (en) | Therapeutic liposome composition and method | |
AU3426497A (en) | Knotting element for use in suturing anatomical tissue and methods therefor | |
AU1589995A (en) | Anti-withering composition for pines and anti-withering method | |
IL127153A0 (en) | Fragments of leptin (ob protein) | |
AU2079397A (en) | Improved connectors and methods | |
AU4538597A (en) | Method for assessing oxidative stress and its control in humans | |
AU2428095A (en) | Testable solid state switch and related method | |
AU1077397A (en) | Chromatographic method for the identification and characterization of hemoglobin variants in blood | |
AU4750097A (en) | Human reg i-gamma protein | |
AU4480697A (en) | Human nm23-like protein | |
AU9777498A (en) | Telomere repeat binding factors and diagnostic and therapeutic use thereof | |
AU7395096A (en) | Method for facilitating dental diagnosis and treatment | |
AU4006695A (en) | Calcineurin interacting protein compositions and methods | |
AU3451397A (en) | Modified protein g and fragments thereof | |
AU2191297A (en) | Blood testing kit | |
AU4075897A (en) | A leptin binding protein and its use in methods for diagnosing and treating abnormalities of the endogenous leptin pathway | |
AU1538497A (en) | Anti-gp46 antibodies and fragments thereof and their use | |
AU3409497A (en) | Substances for treating leptin pathway abnormalities | |
AU2059395A (en) | Test kit and method for competitive specific binding assay |